<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000101.v3.p1" parentStudy="phs000101.v3.p1" createDate="2011-02-15" modDate="2011-04-06">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;</td><td>Adriano Chi&#242;</td><td>Department of Neuroscience, University of Turin, Turin, Italy</td></tr>
		<tr><td>Principal Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;</td><td>Gabriella Restagno</td><td>Molecular Genetics Unit, Department of Clinical Pathology, A.S.O. O.I.R.M.-S.Anna, Turin, Italy</td></tr>
		<tr><td>Principal Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;</td><td>Gabriele Mora</td><td>Salvatore Maugeri Foundation, Lissone, Italy</td></tr>
		<tr><td>Principal Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;</td><td>Bryan J. Traynor</td><td>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA and Neurology Department, Johns Hopkins University, Baltimore, MD, USA</td></tr>
		<tr><td>Principal Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;</td><td>Adriano Chi&#242;</td><td>Department of Neuroscience, University of Turin, Turin, Italy</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>NIH Genome-Wide Association Studies of Amyotrophic Lateral Sclerosis</StudyNameEntrez>
	<StudyNameReportPage>NIH Genome-Wide Association Studies of Amyotrophic Lateral Sclerosis</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
		<StudyType>Case Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The cause of sporadic amyotrophic lateral sclerosis (ALS) is unknown. To identify the genetic factors underlying this fatal 	neurodegenerative disease, we performed a series of genome-wide association studies of ALS. These studies are divided into 	three distinct stages, each associated with a separate data release. A description of each stage is provided below.</p> 	<p>In the first stage, we genotyped 555,352 SNPs in 276 US cases diagnosed with ALS and 271 US controls. These samples were 	obtained from the National Institute of Neurological Disorders and Stroke (NINDS) DNA Repository at Coriell. The 276 US cases 	were genotyped on Illumina HumanHap550v1.1 SNP arrays, whereas the 271 US controls were genotyped on both Illumina HumanHap250Sv1.0 	and Illumina HumanHap300v1.1 SNP arrays. The genotype data was released in June 2008 under the accession number 	<a href="./study.cgi?study_id=phs000101.v1.p1">phs000101.v1.p1</a> and was associated with the following publication: 	Schymick JC et al. (2007) <a href="http://www.ncbi.nlm.nih.gov/pubmed/17362836" target="_blank">Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data</a>. 	<i>Lancet Neurology</i> 6:322-8.</p> 	<p>In the second stage, we extended our genotyping to a larger cohort to identify risk factors with lower effect size. This 	portion of the project used a two-step approach: in step A, 545,066 SNPs were genotyped in 553 individuals with ALS 	and 2,338 controls. Of note, this cohort included data from the 276 US cases and 271 US controls that had been previously 	released in the first stage, <a href="./study.cgi?study_id=phs000101.v1.p1">phs000101.v1.p1</a>. The additional 277 ALS 	cases that were newly genotyped in this stage were collected in a population-based manner from the North of Italy and were 	genotyped on Illumina HumanHap550v1.1 SNP arrays. In step B, we brought forward the 7,600 most associated SNPs from step A, 	and genotyped them in an additional cohort consisting of 2,160 cases and 3,008 controls using an Illumina iSelect custom 	designed SNP array. The new data generated from this study was released in May 2010 (<a href="./study.cgi?study_id=phs000101.v2.p1">phs000101.v2.p1</a>) 	and consisted of 1,456 case samples and 773 control samples for which participants provided consent to make their data 	publicly available. We do not have permission to publicly release the genotype data from the rest of the samples. This data 	release was associated with the following publication: Chi&#242; A et al. (2009) 	<a href="http://www.ncbi.nlm.nih.gov/pubmed/19193627" target="_blank">A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis</a>. 	<i>Human Molecular Genetics</i> 18:1524-32.</p> 	<p>In the third stage, we genotyped 601,273 SNPs in an additional set of 236 Italian ALS cases. Together with the 264 Italian 	samples genotyped as part of stage 2, this brought the total number of samples that were whole genome genotyped samples to 504. These additional 236 patients 	had been collected in a population-based manner from the Piedmonte region in the North of Italy, and were genotyped using 	Illumina Human610Quad.v1 SNP arrays. The rational for this stage of the study arose from a <i>Proceedings of the National Academy of Sciences (PNAS)</i>  	publication by Landers et al. 2009, hypothesizing that genetic variation on chromosome 1q24 in the 	vicinity of the KIFAP3 gene was associated with a significant improvement in survival of ALS patients. Our data failed to 	replicate this finding suggesting that the original finding may have been a false positive finding. The data generated for 	the extra 236 Italian ALS cases used in this study was released in April 2011 (<a href="./study.cgi?study_id=phs000101.v3.p1">phs000101.v3.p1</a>). This data release 	was associated with the following publication: Traynor BJ et al. (2010) 	<a href="http://www.ncbi.nlm.nih.gov/pubmed/20566859" target="_blank">Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients</a>. 	PNAS 107:12335-8. Of note, 95 of these 236 samples had also been genotyped on the Illumina iSelect custom designed SNP array used in the    second stage of this study (see README.txt file available through dbGaP Authorized Access for list of the 95 samples).</p>  	<p>This study utilized the <a href="./study.cgi?id=phs000006">NINDS Repository Motor Neuron Disease/ALS Study</a>, 	and <a href="./study.cgi?id=phs000004">neurologically normal controls</a> from the sample population which are banked 	in the National Institute of Neurological Disorders and Stroke (NINDS Repository) collection.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Inclusion/exclusion criteria for cases</b></p> 	<p>All DNA samples were obtained from patients who: 		<ol type="a"> 			<li>had been diagnosed with probable, probable-laboratory supported or definite ALS according to the El Escorial 			diagnostic criteria published by the World Federation of Neurology;</li> 			<li>were White and non-Hispanics (by self-report);</li> 			<li>had signed informed consent.</li> 		</ol> 	</p> 	<p><b>Inclusion/exclusion criteria for controls</b></p> 	<p>All DNA samples were obtained from patients who: 	   <ol type="a"> 			<li>were neurologically normal;</li> 			<li>were White and non-Hispanics (by self-report);</li> 			<li>had signed informed consent.</li> 		</ol> 	</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="19193627"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17362836"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20566859"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Amyotrophic Lateral Sclerosis"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Adriano Chi&#242;</AttName>
			<Institution>Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Gabriella Restagno</AttName>
			<Institution>Molecular Genetics Unit, Department of Clinical Pathology, A.S.O. O.I.R.M.-S.Anna, Turin, Italy</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Gabriele Mora</AttName>
			<Institution>Salvatore Maugeri Foundation, Lissone, Italy</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Bryan J. Traynor</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA and Neurology Department, Johns Hopkins University, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Michael Nalls</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Shiao-Lin Lai</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>J. Raphael Gibbs</AttName>
			<Institution>Computational Biology Core, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Jennifer C. Schymick</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Sampath Arepalli</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Dena Hernandez</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Marcel van der Brug</AttName>
			<Institution>Cell Biology and Gene Expression Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA and Department of Neuroscience, The Scripps Research Institute, Jupiter, FL, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Allissa Dillman</AttName>
			<Institution>Cell Biology and Gene Expression Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Mark Cookson</AttName>
			<Institution>Cell Biology and Gene Expression Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Christina Moglia</AttName>
			<Institution>Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Andrea Calvo</AttName>
			<Institution>Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Funding Source - &quot;Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients&quot;">
			<AttName>Z01-AG000949-02</AttName>
			<Institution>The Intramural Research Program of the National Institute on Aging, USA</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Adriano Chi&#242;</AttName>
			<Institution>Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Gabriella Restagno</AttName>
			<Institution>Molecular Genetics Unit, Department of Clinical Pathology, A.S.O. O.I.R.M.-S.Anna, Turin, Italy</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Andrew Singleton</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>John Hardy</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Bryan J. Traynor</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA and Neurology Department, Johns Hopkins University, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Jennifer C. Schymick</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Sonja W. Scholz</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Federica Lombardo</AttName>
			<Institution>Molecular Genetics Unit, Department of Clinical Pathology, A.S.O. O.I.R.M.-S.Anna, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Shiao-Lin Lai</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Gabriele Mora</AttName>
			<Institution>Salvatore Maugeri Foundation, Lissone, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Hon-Chung Fung</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Angela Britton</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Sampath Arepalli</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>J. Raphael Gibbs</AttName>
			<Institution>Computational Biology Core, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Michael Nalls</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Stephen Berger</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Lydia Coulter Kwee</AttName>
			<Institution>Center for Human Genetics, Duke University Medical Center, Durham, NC, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Eugene Z. Oddone</AttName>
			<Institution>Department of Medicine, Duke University Medical Center, Durham, NC, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Jinhui Ding</AttName>
			<Institution>Computational Biology Core, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Cynthia Crews</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Ian Rafferty</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Nicole Washecka</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Dena Hernandez</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Luigi Ferrucci</AttName>
			<Institution>Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Stefania Bandinelli</AttName>
			<Institution>Geriatric Unit, Azienda Sanitaria di Firenze, Florence, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Jack Guralnik</AttName>
			<Institution>Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Fabio Macciardi</AttName>
			<Institution>Department of Science and Biomedical Technology, University of Milan, Milan, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Federica Torri</AttName>
			<Institution>Department of Science and Biomedical Technology, University of Milan, Milan, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Sara Lupoli</AttName>
			<Institution>INSPE, San Raffaele Scientific Institute, Milan, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Stephen J. Chanock</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Gilles Thomas</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>David J. Hunter</AttName>
			<Institution>Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Christian Gieger</AttName>
			<Institution>Institute of Epidemiology, Helmholtz Zentrum M&#252;nchennchen, German Research Center for Environmental Health, Neuherberg/Munich, Germany</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>H. Erich Wichmann</AttName>
			<Institution>Institute of Epidemiology, Helmholtz Zentrum M&#252;nchennchen, German Research Center for Environmental Health, Neuherberg/Munich, Germany</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Andrea Calvo</AttName>
			<Institution>Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Roberto Mutani</AttName>
			<Institution>Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Stefania Battistini</AttName>
			<Institution>Department of Neuroscience, Neurology Section, University of Siena, Siena, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Fabio Giannini</AttName>
			<Institution>Department of Neuroscience, Neurology Section, University of Siena, Siena, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Claudia Caponnetto</AttName>
			<Institution>Department of Neuroscience, Ophthalmology and Genetics, University of Genoa, Genoa, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Giovanni Luigi Mancardi</AttName>
			<Institution>Department of Neuroscience, Ophthalmology and Genetics, University of Genoa, Genoa, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Vincenzo La Bella</AttName>
			<Institution>Department of Clinical Neurosciences, University of Palermo, Sicily, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Francesca Valentino</AttName>
			<Institution>Department of Clinical Neurosciences, University of Palermo, Sicily, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Maria Rosaria Monsurr&#242;</AttName>
			<Institution>Department of Neurological Sciences, Second University of Naples, Caserta, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Gioacchino Tedeschi</AttName>
			<Institution>Department of Neurological Sciences, Second University of Naples, Caserta, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Kalliopi Marinou</AttName>
			<Institution>Salvatore Maugeri Foundation, Lissone, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Mario Sabatelli</AttName>
			<Institution>Neurological Institute, Catholic University and I.CO.M.M. Association for ALS Research, Rome, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Amelia Conte</AttName>
			<Institution>Neurological Institute, Catholic University and I.CO.M.M. Association for ALS Research, Rome, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Jessica Mandrioli</AttName>
			<Institution>Department of Neuroscience, S. Agostino - Estense Hospital and University of Modena, Modena, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Patrizia Sola</AttName>
			<Institution>Department of Neuroscience, S. Agostino - Estense Hospital and University of Modena, Modena, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Fabrizio Salvi</AttName>
			<Institution>Department of Neurology, Center for Diagnosis and Cure of Rare Diseases, Bellaria Hospital, Bologna, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Ilaria Bartolomei</AttName>
			<Institution>Department of Neurology, Center for Diagnosis and Cure of Rare Diseases, Bellaria Hospital, Bologna, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Gabriele Siciliano</AttName>
			<Institution>Department of Neuroscience, University of Pisa, Pisa, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Cecilia Carlesi</AttName>
			<Institution>Department of Neuroscience, University of Pisa, Pisa, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Richard W. Orrell</AttName>
			<Institution>University Department of Clinical Neurosciences, Institute of Neurology, University College London, London</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Kevin Talbot</AttName>
			<Institution>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Zachary Simmons</AttName>
			<Institution>Department of Neurology, Penn State College of Medicine, Hershey, PA, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>James Connor</AttName>
			<Institution>Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Erik P. Pioro</AttName>
			<Institution>Department of Neurology, Cleveland Clinic, Cleveland, OH, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Travis Dunkley</AttName>
			<Institution>Neurogenomics Division, Translational Genomics Institute (TGEN), Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Dietrich A. Stephan</AttName>
			<Institution>Neurogenomics Division, Translational Genomics Institute (TGEN), Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Dalia Kasperaviciute</AttName>
			<Institution>Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Elizabeth M. Fisher</AttName>
			<Institution>Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Sibylle Jabonka</AttName>
			<Institution>Institute of Clinical Neurobiology, University of Wuerzburg, Wuerzburg, Germany</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Michael Sendtner</AttName>
			<Institution>Institute of Clinical Neurobiology, University of Wuerzburg, Wuerzburg, Germany</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Marcus Beck</AttName>
			<Institution>Institute of Clinical Neurobiology, University of Wuerzburg, Wuerzburg, Germany</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Lucie Bruijn</AttName>
			<Institution>The ALS Association, Palm Harbor, FL, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Jeffrey Rothstein</AttName>
			<Institution>Department of Neurology, Johns Hopkins University, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Silke Schmidt</AttName>
			<Institution>Center for Human Genetics, Duke University Medical Center, Durham, NC, USA</Institution>
		</Header>
		<Header title="Funding Source - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>Z01 AG000949-02</AttName>
			<Institution>Intramural Research Program of the National Institute on Aging, USA</Institution>
		</Header>
		<Header title="Funding Source - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>2005-10 to FL</AttName>
			<Institution>Istituto Superiore di Sanit224;, Italy</Institution>
		</Header>
		<Header title="Funding Source - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>ES01324</AttName>
			<Institution>National Institutes of Health, USA</Institution>
		</Header>
		<Header title="Funding Source - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>CSP #500A</AttName>
			<Institution>The Department of Veterans Affairs Cooperative Studies Program (CSP), USA</Institution>
		</Header>
		<Header title="Funding Source - &quot;A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis&quot;">
			<AttName>CSP #478</AttName>
			<Institution>The Department of Veterans Affairs Cooperative Studies Program (CSP), USA</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>John Hardy</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Bryan J. Traynor</AttName>
			<Institution>SDGE, NIMH, NIH, Bethesda, MD, USA and Neurology Department, Johns Hopkins University, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Jennifer C. Schymick</AttName>
			<Institution>Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Sonja W. Scholz</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Hon-Chung Fung</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Angela Britton</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Sampath Arepalli</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>J. Raphael Gibbs</AttName>
			<Institution>Computational Biology Core, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Federica Lombardo</AttName>
			<Institution>Molecular Genetics Unit, Department of Clinical Pathology, A.S.O. O.I.R.M.-S.Anna, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>M. Matarin</AttName>
			<Institution>Molecular Genetic Unit, NIA, NIH, Bethesda, MD</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>D. Kasperaviciute</AttName>
			<Institution>Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London, UK</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>D.G. Hernandez</AttName>
			<Institution>Molecular Genetic Unit, NIA, NIH, Bethesda, MD</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>C. Crews</AttName>
			<Institution>Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>L. Bruijn</AttName>
			<Institution>ALS Association, Palm Harbor, FL</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>J. Rothstein</AttName>
			<Institution>Neurology Department, Johns Hopkins University, Baltimore, MD</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>G. Mora</AttName>
			<Institution>Division of Neurorehabilitation, Istituto Scientifico di Pavia, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>G. Restagno</AttName>
			<Institution>Department of Clinical Pathology, ASO OIRM-S Anna, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Adriano Chi&#242;</AttName>
			<Institution>Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Andrew Singleton</AttName>
			<Institution>Molecular Genetic Unit, NIA, NIH, Bethesda, MD</Institution>
		</Header>
		<Header title="NINDS Repository Project Officer - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Katrina A. Gwinn</AttName>
			<Institution>National Institute for Neurological Disorders and Stroke, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="NINDS Repository Principal Investigator - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Roderick A. Corriveau</AttName>
			<Institution>Coriell Institute for Medical Research, Camden, NJ, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>H. Mitsumoto</AttName>
			<Institution>Eleanor and Lou Gehrig MDA/ALS Research Center, Columbia University, New York, NY, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>R.H. Brown</AttName>
			<Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>M. Cudkowicz</AttName>
			<Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>P.H. Gordon</AttName>
			<Institution>Eleanor and Lou Gehrig MDA/ALS Research Center, Columbia University, New York, NY, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>E.J. Kasarkis</AttName>
			<Institution>University of Kentucky, Lexington, KY, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>P. Kaufmann</AttName>
			<Institution>Eleanor and Lou Gehrig MDA/ALS Research Center, Columbia University, New York, NY, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>R. Miller</AttName>
			<Institution>California Pacific Medical Center, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>E. Sorenson</AttName>
			<Institution>Mayo Medical Center, Rochester, MN, USA</Institution>
		</Header>
		<Header title="Clinical Investigators, ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>R. Tandan</AttName>
			<Institution>University of Vermont, Burlington, VT, USA</Institution>
		</Header>
		<Header title="The ALSRG - &quot;Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data&quot;">
			<AttName>Various members, Academic Neurologists</AttName>
			<Institution>See Kaufmann P, Misumoto H (2006) ALS Research Group (ALSRG): Second meeting, a summary report. Amyotrophic Lateral Sclerosis 7: 252-255.</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="NINDS Amyotrophic Lateral Sclerosis" url="http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/amyotrophiclateralsclerosis.htm"/>
		<Url name="NINDS Repository at Coriell Motor Neuron Diseases Resources" url="http://ccr.coriell.org/Sections/Collections/NINDS/?SsId=10"/>
	</StudyURLs>
	<StudyHistory><![CDATA[
<p>This study is divided into three stages. The first stage was entitled "Genome-wide genotyping in amyotrophic lateral sclerosis and 	neurologically normal controls: first stage analysis and public release of data", and was published in <i>Lancet Neurology</i> in 2007 	(<a href="http://www.ncbi.nlm.nih.gov/pubmed/17362836" target="_blank">Schymick et al., 6(4):322-8</a>). The data from the first 	stage analysis was made available on the dbGAP website (study accession: <a href="./study.cgi?id=phs000101">phs000101.v1.p1</a>), 	and was used in the second stage (see below).</p> 	<p>The second stage was entitled "A two-stage genome wide association study of sporadic amyotrophic lateral sclerosis" and 	was published in <i>Human Molecular Genetics</i> in 2009 	(<a href="http://www.ncbi.nlm.nih.gov/pubmed/19193627" target="_blank">Chi&#242; et al, 18(8):1524-32</a>). The data from the 	second stage analysis was made available on the dbGAP website (study accession: <a href="./study.cgi?id=phs000101">phs000101.v2.p1</a>). 	This paper utilized data from 2,713 case samples and 5,346 control samples. This release of data includes 1,456 case samples 	and 773 control samples for which participants provided consent to make their data publicly available. We do not have permission 	to publicly release the genotype data from the rest of the samples.</p> 	<p>The third stage was entitled "Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients" 	and was published in <i>Proceedings of the National Academy of Sciences</i> in 2010 	(<a href="http://www.ncbi.nlm.nih.gov/pubmed/20566859" target="_blank">Traynor et al, 107(27):12335-8</a>). The data from the third 	stage analysis was made available on the dbGAP website (study accession: phs000101.v3.p1). This paper utilized data from 504 case 	samples. This release of data includes 500 case samples for which participants provided consent to make their data publicly available. 	Of note, 264 of these samples were previously released as part of the Chi&#242; et al paper (see above), and 236 samples have not been 	previously released. The 264 previously released samples were genotyped on Illumina HumanHap550v1.1 SNP chips,    whereas the 236 newly released samples were genotyped on Illumina Human610Quadv1 SNP chips. Please note that 95 of the 236    samples for which whole genome data is being released in the third stage had also been genotyped on the Illumina iSelect custom    designed SNP array used in the second stage of this study (see README.txt file available through dbGaP Authorized Access for    list of the 95 samples).</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NINDS</DacName>
      <DacFullName>National Institute of Neurological Disorders and Stroke</DacFullName>
      <DacEmail>ninds-dac@mail.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>301-402-1501</DacFax>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000101.v3.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000101.v3.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000101.v3.p1" FileName="ALS_GWAS_Hardy_NINDSDUC_rev012110_clean.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>These data will be used only for research purposes. They will not be used to determine the individual identity of any person or their relationship to another person.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd000581.1" type="consent-form" createDate="2007-10-19" modDate="2011-03-03" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd000581.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000101.v3.p1&amp;phd=581">
      <OrigName>NINDS DbGaP Participant Protection Policy</OrigName>
      <DisplayName>Participant Protection Policy FAQ</DisplayName>
      <Description>Participant Protection Policy FAQ</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd000583.1" type="consent-form" createDate="2007-10-19" modDate="2011-03-03" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd000583.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000101.v3.p1&amp;phd=583">
      <OrigName>icmodel</OrigName>
      <DisplayName>SAMPLE INFORMED CONSENT LANGUAGE</DisplayName>
      <Description>SAMPLE INFORMED CONSENT LANGUAGE</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd000585.1" type="questionnaire" createDate="2007-10-19" modDate="2011-03-03" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd000585.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000101.v3.p1&amp;phd=585">
      <OrigName>mnd_cde</OrigName>
      <DisplayName>MOTOR NEURON DISORDERS CLINICAL DATA ELEMENTS</DisplayName>
      <Description>MOTOR NEURON DISORDERS CLINICAL DATA ELEMENTS</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd000586.1" type="questionnaire" createDate="2007-10-19" modDate="2011-03-03" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd000586.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000101.v3.p1&amp;phd=586">
      <OrigName>ctl_cde</OrigName>
      <DisplayName>Control Clinical Data Elements</DisplayName>
      <Description>Control Clinical Data Elements</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd002269.1" type="protocol" createDate="2009-12-22" modDate="2011-03-03" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd002269.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000101.v3.p1&amp;phd=2269">
      <OrigName>two stage GWAS of sporadic ALS.pdf</OrigName>
      <DisplayName>A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis</DisplayName>
      <Description>A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>

  <Annotations>
    <DocumentPart phd="phd000585.1" sectionId="V10">
      <phvList>
        <phvRef variableId="24106"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V102">
      <phvList>
        <phvRef variableId="24124"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V11">
      <phvList>
        <phvRef variableId="24107"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V12">
      <phvList>
        <phvRef variableId="24108"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V13">
      <phvList>
        <phvRef variableId="24109"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V14">
      <phvList>
        <phvRef variableId="24111"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V18">
      <phvList>
        <phvRef variableId="24117"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V2">
      <phvList>
        <phvRef variableId="24100"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V21">
      <phvList>
        <phvRef variableId="24121"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V24">
      <phvList>
        <phvRef variableId="24118"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V27">
      <phvList>
        <phvRef variableId="24119"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V30">
      <phvList>
        <phvRef variableId="24120"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V33">
      <phvList>
        <phvRef variableId="24125"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V34">
      <phvList>
        <phvRef variableId="24126"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V35">
      <phvList>
        <phvRef variableId="24127"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V36">
      <phvList>
        <phvRef variableId="24128"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V37">
      <phvList>
        <phvRef variableId="24129"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V38">
      <phvList>
        <phvRef variableId="24130"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V39">
      <phvList>
        <phvRef variableId="24131"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V40">
      <phvList>
        <phvRef variableId="24132"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V41">
      <phvList>
        <phvRef variableId="24133"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V42">
      <phvList>
        <phvRef variableId="24134"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V43">
      <phvList>
        <phvRef variableId="24135"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V44">
      <phvList>
        <phvRef variableId="24136"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V45">
      <phvList>
        <phvRef variableId="24137"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V46">
      <phvList>
        <phvRef variableId="24138"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V47">
      <phvList>
        <phvRef variableId="24139"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V48">
      <phvList>
        <phvRef variableId="24140"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V49">
      <phvList>
        <phvRef variableId="24141"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V5">
      <phvList>
        <phvRef variableId="24102"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V50">
      <phvList>
        <phvRef variableId="24143"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V51">
      <phvList>
        <phvRef variableId="24142"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V55">
      <phvList>
        <phvRef variableId="24147"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V58">
      <phvList>
        <phvRef variableId="24148"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V6">
      <phvList>
        <phvRef variableId="24103"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V60">
      <phvList>
        <phvRef variableId="24157"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V62">
      <phvList>
        <phvRef variableId="24158"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V67">
      <phvList>
        <phvRef variableId="24153"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V68">
      <phvList>
        <phvRef variableId="24154"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V69">
      <phvList>
        <phvRef variableId="24156"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V7">
      <phvList>
        <phvRef variableId="24104"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V70">
      <phvList>
        <phvRef variableId="24155"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V72">
      <phvList>
        <phvRef variableId="24149"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V73">
      <phvList>
        <phvRef variableId="24150"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V74">
      <phvList>
        <phvRef variableId="24152"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V75">
      <phvList>
        <phvRef variableId="24151"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V77">
      <phvList>
        <phvRef variableId="24113"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V78">
      <phvList>
        <phvRef variableId="24114"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V79">
      <phvList>
        <phvRef variableId="24116"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V8">
      <phvList>
        <phvRef variableId="24105"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V80">
      <phvList>
        <phvRef variableId="24115"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V82">
      <phvList>
        <phvRef variableId="24123"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V85">
      <phvList>
        <phvRef variableId="24122"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V88">
      <phvList>
        <phvRef variableId="24112"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V9">
      <phvList>
        <phvRef variableId="24110"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V93">
      <phvList>
        <phvRef variableId="24144"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V94">
      <phvList>
        <phvRef variableId="24146"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000585.1" sectionId="V96">
      <phvList>
        <phvRef variableId="24145"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V12">
      <phvList>
        <phvRef variableId="24162"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V13">
      <phvList>
        <phvRef variableId="24164"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V15">
      <phvList>
        <phvRef variableId="24163"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V17">
      <phvList>
        <phvRef variableId="24169"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V19">
      <phvList>
        <phvRef variableId="24224"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V2">
      <phvList>
        <phvRef variableId="24159"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V23">
      <phvList>
        <phvRef variableId="24195"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V24">
      <phvList>
        <phvRef variableId="24196"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V25">
      <phvList>
        <phvRef variableId="24197"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V26">
      <phvList>
        <phvRef variableId="24198"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V27">
      <phvList>
        <phvRef variableId="24199"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V28">
      <phvList>
        <phvRef variableId="24200"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V29">
      <phvList>
        <phvRef variableId="24201"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V3">
      <phvList>
        <phvRef variableId="24168"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V30">
      <phvList>
        <phvRef variableId="24202"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V31">
      <phvList>
        <phvRef variableId="24203"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V32">
      <phvList>
        <phvRef variableId="24204"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V33">
      <phvList>
        <phvRef variableId="24205"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V34">
      <phvList>
        <phvRef variableId="24206"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V35">
      <phvList>
        <phvRef variableId="24207"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V36">
      <phvList>
        <phvRef variableId="24208"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V37">
      <phvList>
        <phvRef variableId="24209"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V38">
      <phvList>
        <phvRef variableId="24210"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V39">
      <phvList>
        <phvRef variableId="24211"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V4">
      <phvList>
        <phvRef variableId="24167"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V40">
      <phvList>
        <phvRef variableId="24212"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V40a">
      <phvList>
        <phvRef variableId="24214"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V41">
      <phvList>
        <phvRef variableId="24215"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V42">
      <phvList>
        <phvRef variableId="24216"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V43">
      <phvList>
        <phvRef variableId="24217"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V44">
      <phvList>
        <phvRef variableId="24218"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V45">
      <phvList>
        <phvRef variableId="24213"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V53">
      <phvList>
        <phvRef variableId="24170"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V54">
      <phvList>
        <phvRef variableId="24171"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V55">
      <phvList>
        <phvRef variableId="24172"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V56">
      <phvList>
        <phvRef variableId="24173"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V57">
      <phvList>
        <phvRef variableId="24174"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V58">
      <phvList>
        <phvRef variableId="24175"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V59">
      <phvList>
        <phvRef variableId="24176"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V60">
      <phvList>
        <phvRef variableId="24177"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V61">
      <phvList>
        <phvRef variableId="24178"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V62">
      <phvList>
        <phvRef variableId="24179"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V63">
      <phvList>
        <phvRef variableId="24180"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V64">
      <phvList>
        <phvRef variableId="24181"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V65">
      <phvList>
        <phvRef variableId="24182"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V66">
      <phvList>
        <phvRef variableId="24183"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V67">
      <phvList>
        <phvRef variableId="24184"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V68">
      <phvList>
        <phvRef variableId="24185"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V69">
      <phvList>
        <phvRef variableId="24186"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V70">
      <phvList>
        <phvRef variableId="24187"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V71">
      <phvList>
        <phvRef variableId="24189"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V72">
      <phvList>
        <phvRef variableId="24190"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V73">
      <phvList>
        <phvRef variableId="24191"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V74">
      <phvList>
        <phvRef variableId="24192"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V75">
      <phvList>
        <phvRef variableId="24193"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V76b">
      <phvList>
        <phvRef variableId="24188"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V78">
      <phvList>
        <phvRef variableId="24222"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V79">
      <phvList>
        <phvRef variableId="24223"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V80">
      <phvList>
        <phvRef variableId="24220"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V81">
      <phvList>
        <phvRef variableId="24221"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V82">
      <phvList>
        <phvRef variableId="24219"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd000586.1" sectionId="V9">
      <phvList>
        <phvRef variableId="24161"/>
      </phvList>
    </DocumentPart>
  </Annotations>


<Analyses>
	<Analysis pha="2846" genomeBuild="36.3" snpBuild="129" analysisType="">
		<Description><![CDATA[
This analysis of association between genotype and the amyotrophic lateral sclerosis (ALS) disease status defined by <a href=?http://www.ninds.nih.gov/"> EL Escorial diagnostic criteria</a> was computed by Traynor&#39;s group. It contained 276 cases and 271 neurologically normal controls which were derived from the <a href="http://ccr.coriell.org/ninds/index.html" > NINDS Neurogenetics repository at Coriell Cell Repositories</a>. The genotyping data was generated and provided by the laboratory of Dr. Andrew Singleton, NIA, Dr. Bryan J. Traynor, NINDS, and Dr. John Hardy, NIA using the Illumina Infinium II HumanHap240S, Infinium II HumanHap300 and Infinium II HumanHap550v1 chips (NIH Intramural funding from NIA and NINDS, additional funding from the ALS Association and the Packard Center for ALS Research at Johns Hopkins).
		]]></Description>
		<Method>Tests for Association Using Cochran-Armitage Test on Genotype Frequencies</Method>
		<GtyPlatform probeNum="555352" snpBatchId="38431">
			<Vendor>Illumina</Vendor>
			<VendorURL>550v1 only</VendorURL>
			<Platform>HumanHap550v1</Platform>
		</GtyPlatform>
		<Comment></Comment>
	</Analysis>
</Analyses>

</Study>

</Studies>

</GaPExchange>
